» Authors » Peter Platteau

Peter Platteau

Explore the profile of Peter Platteau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 319
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adriaenssens T, Van Vaerenbergh I, Van Landuyt L, Verheyen G, De Brucker M, Camus M, et al.
PLoS One . 2024 Jan; 19(1):e0297040. PMID: 38295095
Research Question: Can a strategy for scoring oocyte quality, based on cumulus cell (CC) gene expression, prioritize oocytes with the highest implantation potential, while limiting the number of embryos to...
2.
Filippi F, Reschini M, Polledri E, Cecchele A, Guarneri C, Vigano P, et al.
PLoS One . 2023 Mar; 18(3):e0280238. PMID: 36976781
Background: In women scheduled for cancer treatment, oocytes cryopreservation is a well-established procedure. Random start protocols have been a substantial improvement in this setting, allowing to prevent delay in the...
3.
Van Vaerenbergh I, Adriaenssens T, Coucke W, Van Landuyt L, Verheyen G, De Brucker M, et al.
Reprod Biol Endocrinol . 2021 Feb; 19(1):26. PMID: 33608027
Background: Non-invasive oocyte quality scoring, based on cumulus gene expression analysis, in combination with morphology scoring, can increase the clinical pregnancy (CPR) and live birth rates (LBR) in Day 3...
4.
Smitz J, Platteau P
Reprod Biol Endocrinol . 2020 Aug; 18(1):80. PMID: 32762698
It is widely known that luteinising hormone (LH) and human chorionic gonadotrophin (hCG) are integral in the female reproductive lifecycle. Due to the common binding site and similarity in molecular...
5.
Polyzos N, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, et al.
Reprod Biomed Online . 2012 Mar; 24(5):532-9. PMID: 22417669
Evidence regarding the role of anti-Müllerian hormone (AMH) among oocyte donors is limited and only involves gonadotrophin-releasing hormone (GnRH)-agonist-treated donors. This trial assessed the predictive ability of AMH for ovarian...
6.
Stoop D, De Munck N, Jansen E, Platteau P, Van den Abbeel E, Verheyen G, et al.
Reprod Biomed Online . 2012 Jan; 24(2):180-5. PMID: 22222248
Controversy exists about the risk of microbiological contamination from direct contact with unsterile liquid nitrogen during oocyte vitrification. The aim of this observational study was to evaluate the effectiveness of...
7.
Reichenbach J, Van de Velde H, De Rycke M, Staessen C, Platteau P, Baetens P, et al.
Pediatrics . 2008 Sep; 122(3):e778-82. PMID: 18762514
Allogeneic hematopoietic stem cell transplantation from an human leukocyte antigen (HLA)-identical donor is currently the only proven curative treatment for chronic granulomatous disease. Hematopoietic stem cell transplantation with alternative donors...
8.
Platteau P, Nyboe Andersen A, Loft A, Smitz J, Danglas P, Devroey P
Reprod Biomed Online . 2008 Aug; 17(2):190-8. PMID: 18681992
The objective of this study was to compare the live birth rates resulting from ovarian stimulation with highly purified human menopausal gonadotrophin (HP-HMG), which combines FSH and human chorionic gonadotrophin-driven...
9.
Nyboe Andersen A, Balen A, Platteau P, Devroey P, Helmgaard L, Arce J
Hum Reprod . 2008 Mar; 23(6):1424-30. PMID: 18372254
Unlabelled: BACKGROUND The objective of this investigation was to establish independent predictors of follicle-stimulating hormone (FSH) threshold dose in anovulatory women undergoing ovulation induction with FSH preparations. Methods: One hundred...
10.
Balen A, Platteau P, Nyboe Andersen A, Devroey P, Helmgaard L, Arce J
Hum Reprod . 2007 Apr; 22(7):1816-23. PMID: 17449511
Background: The objective of this study was to demonstrate non-inferiority of a highly purified urinary follicle stimulating hormone (HP-FSH) preparation compared with a recombinant (rFSH) preparation with respect to ovulation...